ArticleNeuro-oncology advances

Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.

Shiao-Pei Weathers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.